Reneo Pharmaceuticals Inc
NASDAQ:RPHM
Cash Flow Statement
Cash Flow Statement
Reneo Pharmaceuticals Inc
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||
| Net Income |
(19)
|
(22)
|
(28)
|
(35)
|
(40)
|
(46)
|
(49)
|
(49)
|
(52)
|
(54)
|
(61)
|
(67)
|
(77)
|
(71)
|
(57)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
1
|
2
|
3
|
4
|
5
|
5
|
5
|
4
|
4
|
5
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
1
|
2
|
3
|
5
|
5
|
5
|
5
|
4
|
4
|
3
|
2
|
1
|
1
|
0
|
|
| Change in Working Capital |
1
|
(1)
|
(4)
|
(1)
|
(3)
|
2
|
3
|
3
|
1
|
3
|
7
|
5
|
12
|
(6)
|
(10)
|
|
| Cash from Operating Activities |
(19)
N/A
|
(23)
-22%
|
(29)
-30%
|
(33)
-13%
|
(38)
-14%
|
(38)
-1%
|
(41)
-6%
|
(42)
-3%
|
(47)
-13%
|
(47)
0%
|
(52)
-9%
|
(60)
-15%
|
(64)
-7%
|
(76)
-19%
|
(66)
+12%
|
|
| Investing Cash Flow | ||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
7
|
2
|
(26)
|
(31)
|
(23)
|
(18)
|
18
|
(23)
|
(58)
|
(44)
|
(122)
|
(56)
|
11
|
6
|
97
|
|
| Cash from Investing Activities |
7
N/A
|
2
-71%
|
(26)
N/A
|
(32)
-22%
|
(23)
+26%
|
(18)
+23%
|
18
N/A
|
(23)
N/A
|
(58)
-154%
|
(45)
+23%
|
(123)
-174%
|
(56)
+54%
|
11
N/A
|
6
-45%
|
97
+1 586%
|
|
| Financing Cash Flow | ||||||||||||||||
| Net Issuance of Common Stock |
47
|
95
|
179
|
179
|
132
|
85
|
0
|
0
|
0
|
1
|
65
|
65
|
61
|
60
|
(4)
|
|
| Other |
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Cash from Financing Activities |
47
N/A
|
93
+98%
|
179
+92%
|
179
+0%
|
132
-26%
|
86
-35%
|
0
-100%
|
0
-31%
|
0
+74%
|
1
+213%
|
65
+4 338%
|
65
+0%
|
61
-7%
|
60
-2%
|
(4)
N/A
|
|
| Change in Cash | ||||||||||||||||
| Net Change in Cash |
36
N/A
|
73
+102%
|
124
+70%
|
115
-8%
|
71
-38%
|
30
-58%
|
(22)
N/A
|
(64)
-191%
|
(105)
-63%
|
(91)
+13%
|
(109)
-20%
|
(50)
+54%
|
8
N/A
|
(10)
N/A
|
27
N/A
|
|
| Free Cash Flow | ||||||||||||||||
| Free Cash Flow |
(19)
N/A
|
(23)
-22%
|
(30)
-30%
|
(33)
-14%
|
(38)
-14%
|
(39)
-1%
|
(41)
-6%
|
(42)
-3%
|
(48)
-14%
|
(48)
0%
|
(52)
-9%
|
(60)
-15%
|
(64)
-7%
|
(76)
-18%
|
(66)
+12%
|
|